P1271: THE IMPACT OF CYTOMEGALOVIRUS-SPECIFIC T CELLS USAGE AS ADOPTIVE THERAPY IN PATIENTS WITH PT-CY AND TCR ΑΒ+/CD19+ CELLS DEPLETION AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
Anna Dmitrova,
Mikhail Drokov,
Tatiana Tupoleva,
Dmitriy Tikhomirov,
Grigoriy Efimov,
Apollinariya Bogolyubova,
Alexandra Maleeva,
Murad Vagida,
Zalina Fidarova,
Evgeniy Zvonkov,
Larisa Kuzmina,
Elena Parovichnikova
Affiliations
Anna Dmitrova
1 National Research Center for Hematology, Bone marrow transplantation department, Moscow, Russia
Mikhail Drokov
1 National Research Center for Hematology, Bone marrow transplantation department, Moscow, Russia
Tatiana Tupoleva
2 National Research Center for Hematology, Department of Virology, Moscow, Russia
Dmitriy Tikhomirov
2 National Research Center for Hematology, Department of Virology, Moscow, Russia
Grigoriy Efimov
3 National Research Center for Hematology, Laboratory of transplantation immunology, Moscow, Russia
Apollinariya Bogolyubova
3 National Research Center for Hematology, Laboratory of transplantation immunology, Moscow, Russia
Alexandra Maleeva
3 National Research Center for Hematology, Laboratory of transplantation immunology, Moscow, Russia
Murad Vagida
3 National Research Center for Hematology, Laboratory of transplantation immunology, Moscow, Russia
Zalina Fidarova
4 National Research Center for Hematology, Department of Hematology and Hemoblastosis Chemotherapy, Moscow, Russia
Evgeniy Zvonkov
5 National Research Center for Hematology, Department of lymphoproliferative disorders, Moscow, Russia
Larisa Kuzmina
6 National Research Center for Hematology, Bone marrow transplantation department, Moscow, Russia
Elena Parovichnikova
7 National Research Center for Hematology, Moscow, Russia
